Andrew Beppu, PhD received his bachelor of science in neuroscience and physiology from University of California, San Diego (UCSD), where he conducted research on roles for orosomucoid-like 3 (ORMDL3) mediated pathogenesis of asthma remodeling and airway hyperresponsiveness. Beppu joined the PhD program at Cedars-Sinai in fall 2016 and conducted his thesis research under the tutelage of Barry Stripp, PhD. His project including elucidating the lifecycle of rare lung injury-specific basal cells. His research leveraged the ability to assess the entire transcriptional landscape of a cell afforded by single-cell RNA-seq in conjunction with the generation of novel lineage drivers, to identify progenitors to these rare basal populations and elucidate how downstream immunomodulation regulates post-injury progenitor cell function.